Informations sur le produit
- Naldemedine
- (5α)-17-(Cyclopropylmethyl)-6,7-didehydro-4,5-epoxy-3,6,14-trihydroxy-N-[1-methyl-1-(3-phenyl-1,2,4-oxadiazol-5-yl)ethyl]morphinan-7-carboxamide
- Nalmedine
- Symproic
- Morphinan-7-carboxamide, 17-(cyclopropylmethyl)-6,7-didehydro-4,5-epoxy-3,6,14-trihydroxy-N-[1-methyl-1-(3-phenyl-1,2,4-oxadiazol-5-yl)ethyl]-, (5α)-
Naldemedine is an opioid receptor antagonist that blocks the binding of opioids to their receptors in the central nervous system. It is used for the treatment of opioid use and opioid-induced constipation. Naldemedine has been shown to inhibit the binding of opioids to opioid receptors in peripheral tissues, including blood vessels, intestines, and urinary tract. This drug also blocks the binding of opioids to their receptors in the brain, which decreases pain sensation and prevents respiratory depression. Naldemedine has been clinically tested for its ability to prevent opioid-induced constipation in patients with chronic non-cancer pain and those who are taking long-term opioids for cancer pain management.
Propriétés chimiques
Question d’ordre technique sur : 3D-RLB07289 Naldemedine-d3
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages